Article
Identification of key hub genes in pancreatic ductal adenocarcinoma: an integrative bioinformatics study
28 Mar 2025
Abstract excerpt
Pancreatic Ductal Adenocarcinoma (PDAC) poses a significant health threat characterized by poor clinical outcomes, largely attributable to late detection, chemotherapy resistance, and the absence of tailored therapies. Despite progress in surgical, radiation, and chemotherapy treatments, 80% of PDAC patients do not benefit optimally from systemic therapy, often due to asymptomatic presentation or disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
